Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Adamas Pharmaceuticals IncListing unverified | Buy | $138.5K | conv 33Cluster | SEC | |
Adamas Pharmaceuticals IncListing unverified | Buy | $3.3K | conv 33Cluster | SEC | |
Adamas Pharmaceuticals IncListing unverified | Buy | $896K | conv 50ClusterFirst in 12mo | SEC | |
PROOFPOINT INCListing unverified | Sell | $4.5M | SEC | ||
PROOFPOINT INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PROOFPOINT INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PROOFPOINT INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PROOFPOINT INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PROOFPOINT INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
PROOFPOINT INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |